Analyst Ranking
Bottom 1%
#5128 out of 5165 analysts
Average Return
-8.24%
Win Rate
38%75 out of 199
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-19 -
2024-03-19
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-27 -
2025-02-27
Buy
Haemonetics CorpHAE
+63.87%$50.65$83.00
2025-09-22 -
2026-01-07
Buy
Haemonetics CorpHAE
+62.14%$51.19$83.00
2025-10-20 -
2026-01-07
Buy
Lifecore Biomedical IncLFCR
+54.15%$3.25$5.01
2023-03-20 -
2024-03-20
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verifyme IncVRME
11Buy$1.50+53.37%Maintains
2 days ago
U S Physical Therapy IncUSPH
21Buy$103.00+29.61%Maintains
3 days ago
Dentsply Sirona IncXRAY
22Buy$14.00+13.18%Maintains
3 days ago
Merit Medical Systems IncMMSI
25Buy$106.00+15.66%Maintains
2 months ago
Haemonetics CorpHAE
22Buy$90.00+8.43%Maintains
2 months ago
Anika Therapeutics IncANIK
15Buy$16.00+62.60%Maintains
2 months ago
Henry Schein IncHSIC
18Buy$79.00+1.10%Maintains
2 months ago
Orthofix Medical IncOFIX
4Buy$18.00+14.43%Maintains
2 months ago
Option Care Health IncOPCH
18Buy$38.00+17.50%Maintains
2 months ago
Opko Health IncOPK
11Buy$2.25+65.44%Maintains
2 months ago
Lemaitre Vascular IncLMAT
11Buy$95.00+13.43%Maintains
3 months ago
Modivcare IncMODVQ
13Buy$6.00+2,027.66%Maintains
10 months ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Lifecore Biomedical IncLFCR
9Buy$10.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
5 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.